BioHarvest Sciences Inc.

9.84-0.14 (-1.4%)
Oct 29, 4:00:00 PM EDT · NasdaqGM · BHST · USD

Upcoming Earnings

Report date
Nov 10, 2025 (in 11 days)

Key Stats

Market Cap
192.70M
P/E (TTM)
-
Basic EPS (TTM)
-0.69
Dividend Yield
0%

About

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

CEO
Dr. Zaki Rakib Ph.D.
IPO
1/8/2021
Sector
Consumer Defensive
Industry
Packaged Foods